Drug Pipeline

Orca-T Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05316701 Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic… Acute Myeloid Leukemia Active, Not Recruiting
Phase 2
NCT07216443 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients… Leukemia, Myeloid, Acute Recruiting
Phase 1
NCT06551584 Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT Acute Myeloid Leukemia Recruiting
NCT06195891 Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment… Acute Lymphoblastic Leukemia Recruiting
NCT04013685 Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for… Acute Myeloid Leukemia Active, Not Recruiting
Sponsors Running Orca-T Trials
Orca Biosystems, Inc. (3) City of Hope Medical Center (1) Stanford University (1)
Disease Areas
Leukemia (5) Myelodysplastic Syndromes (MDS) (5) Acute Myeloid Leukemia (AML) (4) Chronic Myeloid Leukemia (CML) (1) Acute Lymphoblastic Leukemia (ALL) (1)
Get alerts when Orca-T trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free